Arrowhead Pharmaceuticals, Inc. (ARWR)

63.84 -2.41 (-3.64%) USD  |  NASDAQ  |  Jan 16, 16:00
64.09 +0.25 (+0.39%) After-Hours: 20:00
More

Arrowhead Pharmaceuticals Outperform Recommendations

Outperform Recommendations Chart

View Outperform Recommendations for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Outperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Outperform Recommendations Range, Past 5 Years

View Outperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Outperform Recommendations Benchmarks

View Outperform Recommendations Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Celcuity, Inc. Upgrade